Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012

Show Health and Fitness Publications

Thu, February 2, 2012

[ Thu, Feb 02nd 2012 ] - Market Wire

International Drug & Explosives Detection Company IDenta Corp. Targets New American Markets

[ Thu, Feb 02nd 2012 ] - Market Wire

Vista Partners Publishes February 2012 Newsletter

[ Thu, Feb 02nd 2012 ] - Market Wire

Pro-Dex, Inc. Announces Fiscal 2012 Second Quarter Financial Results Conference Call and Webcast

[ Thu, Feb 02nd 2012 ] - Market Wire

Prana Comments on Nature Medicine, PNAS and Journ .. icles That Highlight the Role of Metals in Neurol

[ Thu, Feb 02nd 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Valeant .. aceuticals Int (USA) and The Dow Chemical Company

[ Thu, Feb 02nd 2012 ] - Market Wire

Dynavax Reports on Heplisav(TM) Pre-BLA Meeting With FDA

[ Thu, Feb 02nd 2012 ] - Market Wire

$30 Million Due to MMRGlobal Under Non-Exclusive Patent License Agreement

[ Thu, Feb 02nd 2012 ] - Market Wire

OncoSec's President and CEO Explains His Firm's Ambitious List of Milestones for 2012

[ Thu, Feb 02nd 2012 ] - Market Wire

CryoLife Announces Release Date and Teleconferenc .. 011 Fourth Quarter and Year End Financial Results

[ Thu, Feb 02nd 2012 ] - Market Wire

AVI BioPharma to Present Company Overview at the .. Annual BIO CEO &;; Investor Conference

[ Thu, Feb 02nd 2012 ] - Market Wire

Equity Research on Amgen Inc. and Biogen Idec Inc. - Biotech Industry Growing

[ Thu, Feb 02nd 2012 ] - Market Wire

The Methodist Hospital to Pioneer Vascular Research With Hansen Medical Vascular Robotic System

[ Thu, Feb 02nd 2012 ] - Market Wire

Cytomedix Announces Option Extension With Top 20 .. and Intent to Proceed to License Agreement for t

[ Thu, Feb 02nd 2012 ] - Market Wire

YouTube Interview Now Available for Kedem Pharmac .. i Updating Company Progress on Sublingual Drug De

[ Thu, Feb 02nd 2012 ] - Market Wire

Discovery Labs Cleared to Market AFECTAIR in U.S.

[ Thu, Feb 02nd 2012 ] - Market Wire

Horizon Pharma to Present at the 14th Annual BIO CEO and Investor Conference

[ Thu, Feb 02nd 2012 ] - Market Wire

Mylan Receives Tentative FDA Approval for Generic Version of Lipitor

[ Thu, Feb 02nd 2012 ] - Market Wire

Warnex Extends Maturity Date of Its Outstanding Debenture

[ Thu, Feb 02nd 2012 ] - Market Wire

Nuvo Research announces launch of Synera in the U.S.

[ Thu, Feb 02nd 2012 ] - Market Wire

Syneron Announces New Ground Breaking evolastina" Procedure

[ Thu, Feb 02nd 2012 ] - Market Wire

Delcath Announces First European Chemosat Procedures

Wed, February 1, 2012

[ Wed, Feb 01st 2012 ] - Market Wire

Mettler-Toledo International Inc. to Host Fourth-Quarter 2011 Earnings Conference Call

[ Wed, Feb 01st 2012 ] - Market Wire

LifeSci Advisors Announces Investment Opinion on Repligen Corporation

[ Wed, Feb 01st 2012 ] - Market Wire

Critical Alerts For Merck, Best Buy, Lorillard, E .. m Creek Timber Released By Seven Summits Research

[ Wed, Feb 01st 2012 ] - Market Wire

Cyberonics to Report Fiscal Year 2012 Third Quart .. lts and Host Conference Call on February 24, 2012

[ Wed, Feb 01st 2012 ] - Market Wire

AspenBio Sets 2012 AppyScore Anticipated Mileston .. ical Trial for Appendicitis Test Beginning Mid-20

[ Wed, Feb 01st 2012 ] - Market Wire

Ardea Biosciences Prices Public Offering of Common Stock

[ Wed, Feb 01st 2012 ] - Market Wire

Valeant Pharmaceuticals Acquires Probiotica in Brazil

[ Wed, Feb 01st 2012 ] - Market Wire

Daxor Announces That Shertech Pharmacy Corp. Acqu .. ood Volume Analyzer to Service Multiple Hospitals

[ Wed, Feb 01st 2012 ] - Market Wire

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Boston Scientific Announces First Implant and Mar .. h of PROMUS Elementa" Plus Stent System in Europe

[ Wed, Feb 01st 2012 ] - Market Wire

Pfizer and GlaxoSmithKline Optimistic on Growth Prospects

[ Wed, Feb 01st 2012 ] - Market Wire

New Revenues Drivers From Eli Lilly and AstraZeneca Poised to Offset Patent Cliffs

[ Wed, Feb 01st 2012 ] - Market Wire

AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Aethlon Medical Reports Immediate and Rapid Virol .. C (HCV) Patients Receiving Hemopurifier Treatment

[ Wed, Feb 01st 2012 ] - Market Wire

Shire and Sangamo Collaborate to Develop Therapeu .. atment of Hemophilia and Other Monogenic Diseases

[ Wed, Feb 01st 2012 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Implant Sciences' Quantum Sniffer QS-H150 Securit .. to Major Oil Corporation for Deployment in Africa

[ Wed, Feb 01st 2012 ] - Market Wire

Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer

[ Wed, Feb 01st 2012 ] - Market Wire

OncoSec President and CEO Contributes to Physicians News Digest

[ Wed, Feb 01st 2012 ] - Market Wire

PAREXEL and ASAN Medical Center Establish Allianc .. d Drug Development and Commercialization Programs

[ Wed, Feb 01st 2012 ] - Market Wire

Concord Medical Services Holdings Limited Engages .. p LLC to Establish a Strategic Investor Relations

Tue, January 31, 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Generex Announces $2.00 Million Capital Investment

[ Tue, Jan 31st 2012 ] - Market Wire

KineMed annuncia di aver stretto una collaborazio .. per lo sviluppo di approcci innovativi al trattam

[ Tue, Jan 31st 2012 ] - Market Wire

Hospira ernennt Richard Davies zum Chief Commercial Officer

[ Tue, Jan 31st 2012 ] - Market Wire

First Case in VISIUS Surgical Theatre at Florida Hospital

[ Tue, Jan 31st 2012 ] - Market Wire

Exactech Announces Preliminary 2011 Sales of $205 .. llion and 4th Quarter 2011 Sales of $53.1 Million

[ Tue, Jan 31st 2012 ] - Market Wire

Patient Home Monitoring (PHM) Announces Audited F .. cal Quarter 2012 Results and Anticoagulation Clin

[ Tue, Jan 31st 2012 ] - Market Wire

[ Tue, Jan 31st 2012 ] - Market Wire

Dendreon, Delta Air Lines, JDS Uniphase

[ Tue, Jan 31st 2012 ] - Market Wire

Health Netas & UCLAas Health Literacy Social Media Program Opens to All Teens Nationwide

[ Tue, Jan 31st 2012 ] - Market Wire

Community Health Systems Announces Execution of A .. ate with Longview, Texas, Multi-Speciality Clinic

[ Tue, Jan 31st 2012 ] - Market Wire

Catasys Contracts With Coventry Health Care of Oklahoma

[ Tue, Jan 31st 2012 ] - Market Wire

Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies

[ Tue, Jan 31st 2012 ] - Market Wire

Biomerica Launches New Patented Test to Identify .. eloping Severe Side Effects From Thiopurine Drugs

[ Tue, Jan 31st 2012 ] - Market Wire

West to Present at UBS Conference

[ Tue, Jan 31st 2012 ] - Market Wire

Life Technologies Names Alan Sachs as Head of Global Research and Development

[ Tue, Jan 31st 2012 ] - Market Wire

AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Biogen Idec nombra a Kenneth DiPietro Vicepresidente ejecutivo de Recursos Humanos

[ Tue, Jan 31st 2012 ] - Market Wire

Reflect Scientific, Inc. Has Positive Outlook for 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Inovio Pharmaceuticals Moves Closer to "Universal .. trating Protective Immune Responses Against Multi

[ Tue, Jan 31st 2012 ] - Market Wire

Inovio Pharmaceuticals Moves Closer to quot;&# .. luenza Vaccine by Demonstrating Protective Immune

Mon, January 30, 2012

[ Mon, Jan 30th 2012 ] - Market Wire

Greatbatch, Inc. to Participate in the 2012 Canaccord Genuity Musculoskeletal Conference

[ Mon, Jan 30th 2012 ] - Market Wire

Watson Announces New Jersey-Based Global Ramp;;D Technology Center

[ Mon, Jan 30th 2012 ] - Market Wire

ISTA's Board Reiterates Commitment to Maximizing .. hareholder Value Through Strategic Review Process

[ Mon, Jan 30th 2012 ] - Market Wire

AMAG Pharmaceuticals Announces Completion of Enro .. am Evaluating Feraheme for a Broader Iron Deficie

[ Mon, Jan 30th 2012 ] - Market Wire

Allos Therapeutics Requests Re-Examination of CHM .. FOLOTYN in PTCL at the European Medicines Agency

[ Mon, Jan 30th 2012 ] - Market Wire

Alnylam Receives Notice of Allowance from United .. ffice (USPTO) for New Patent Broadly Covering Sec

[ Mon, Jan 30th 2012 ] - Market Wire

Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources

[ Mon, Jan 30th 2012 ] - Market Wire

Community Health Systems, Inc. Finalizes Amendment and Extension of Its Credit Facilities

[ Mon, Jan 30th 2012 ] - Market Wire

Kenneth DiPietro kommt als Executive Vice President, Human Resources zu Biogen Idec

[ Mon, Jan 30th 2012 ] - Market Wire

Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.

[ Mon, Jan 30th 2012 ] - Market Wire

Revaskularisierungsgert von Covidien zur interven .. llen Behandlung bei Schlaganfallstudie zugelassen

[ Mon, Jan 30th 2012 ] - Market Wire

Compugen Presents Three Product Candidates for Tr .. s at the Immunotherapeutics & Immunomonitoring Co

[ Mon, Jan 30th 2012 ] - Market Wire

Dispositivo per la rivascolarizzazione di Covidie .. tazione interventistica sulla gestione dell'ictus

[ Mon, Jan 30th 2012 ] - Market Wire

Implant Sciences Sells Explosives Trace Detection Units for Deployment in Africa

[ Mon, Jan 30th 2012 ] - Market Wire

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

[ Mon, Jan 30th 2012 ] - Market Wire

Le dispositif de revascularisation Covidien appro .. essai visant la gestion interventionnelle des AVC

[ Mon, Jan 30th 2012 ] - Market Wire

Synageva BioPharma Highlights Key Data Presentati .. g Lysosomal Disease Network (LDN) World Symposium

[ Mon, Jan 30th 2012 ] - Market Wire

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases

[ Mon, Jan 30th 2012 ] - Market Wire

Capital Senior Living Corporation to Present at U .. are Services Conference on Wednesday, February 8,

[ Mon, Jan 30th 2012 ] - Market Wire

Wright Medical Group, Inc. Names Daniel Garen Senior Vice President and Chief Compliance Officer

Sat, January 28, 2012

[ Sat, Jan 28th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Health Management Associates, Inc.

[ Sat, Jan 28th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.

Fri, January 27, 2012

[ Fri, Jan 27th 2012 ] - Market Wire

Medisafe 1 Technologies Announces $1MM Stock Repu .. ase Program of 10MM Shares up to 10 Cents a Share

[ Fri, Jan 27th 2012 ] - Market Wire

Bionovo to Voluntarily Delist from NASDAQ

[ Fri, Jan 27th 2012 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in TranS1, Inc. to Inquire About the Le

[ Fri, Jan 27th 2012 ] - Market Wire

Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash

[ Fri, Jan 27th 2012 ] - Market Wire

Illuminaas Board of Directors to Review Unsolicited Tender Offer from Roche

[ Fri, Jan 27th 2012 ] - Market Wire

ZOLL Medical, Vistaprint NV, Corning, Apple and Google

[ Fri, Jan 27th 2012 ] - Market Wire

BIOLASE Signs Strategic Sales and Marketing Partn .. udy Club, a Leading Dental Education Organization

[ Fri, Jan 27th 2012 ] - Market Wire

Medtronic Launches New Minimally Invasive Cardiac .. lusive Distribution Agreement with Miami Instrume

[ Fri, Jan 27th 2012 ] - Market Wire

Boston Scientific, Sirius, Momenta Pharmaceuticals, Gran Tierra Energy, Taseko Mines and TiVo

[ Fri, Jan 27th 2012 ] - Market Wire

Reduce Stress and Help Shoo the Flu

[ Fri, Jan 27th 2012 ] - Market Wire

Centene Corporation to Present at UBS 2012 Healthcare Conference

[ Fri, Jan 27th 2012 ] - Market Wire

CooperVisiona" Helps the Association for the Blind and Visually Impaired

[ Fri, Jan 27th 2012 ] - Market Wire

Tornier Announces 2011 Fourth Quarter and Full Year Conference Call

[ Fri, Jan 27th 2012 ] - Market Wire

WellPoint Launches Innovative Reimbursement Initi .. y Care Physicians to Improve Quality and Reduce M

[ Fri, Jan 27th 2012 ] - Market Wire

GenVec Extends Research Collaboration with Global Pharmaceutical Company

[ Fri, Jan 27th 2012 ] - Market Wire

iBio, Inc. Listing Deficiency Resolved

[ Fri, Jan 27th 2012 ] - Market Wire

Infinity Reports Update from Phase 2 Study of Sar .. ine in Patients with Metastatic Pancreatic Cancer

[ Fri, Jan 27th 2012 ] - Market Wire

El estudio ASCEND evaluar la eficacia de TYSABRI .. o para la esclerosis mltiple secundaria progresiv

[ Fri, Jan 27th 2012 ] - Market Wire

Independent Data Published on BioLife Solutions HypoThermosol and CryoStor

[ Fri, Jan 27th 2012 ] - Market Wire

Dr. Reddyas Clarifies Media Reports

Thu, January 26, 2012

[ Thu, Jan 26th 2012 ] - Market Wire

Aetna Announces Transaction with Vitality Re III

[ Thu, Jan 26th 2012 ] - Market Wire

Theratechnologies to Announce Results for Its 2011 Fiscal Year

[ Thu, Jan 26th 2012 ] - Market Wire

Vista Partners Updates Coverage on OncoSec Medical Inc.;; Target Price $2.50

[ Thu, Jan 26th 2012 ] - Market Wire

Align Technology, Zeltiq Aesthetics & Others

[ Thu, Jan 26th 2012 ] - Market Wire

Align Technology, Zeltiq Aesthetics amp;; Others

[ Thu, Jan 26th 2012 ] - Market Wire

BioReference to Launch Groundbreaking Solid Tumor .. ping Test through its GenPath Oncology Laboratory

[ Thu, Jan 26th 2012 ] - Market Wire

Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors

[ Thu, Jan 26th 2012 ] - Market Wire

Merck to Hold 2011 Full-Year and Fourth-Quarter Sales and Earnings Conference Call on February 2

[ Thu, Jan 26th 2012 ] - Market Wire

Lo studio ASCEND valuter l'efficacia di TYSABRI ( .. o per la sclerosi multipla secondariamente progre

[ Thu, Jan 26th 2012 ] - Market Wire

tude ASCEND pour valuer l'efficacit de TYSABRI (n .. ement pour la sclrose en plaques progressive seco

[ Thu, Jan 26th 2012 ] - Market Wire

ASCEND-Studie zur Prfung der Wirksamkeit von TYSA .. herapie fr sekundr-progrediente Multiple Sklerose

[ Thu, Jan 26th 2012 ] - Market Wire

ASCEND Study to Evaluate the Effectiveness of TYS .. ment for Secondary-Progressive Multiple Sclerosis

[ Thu, Jan 26th 2012 ] - Market Wire

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimeras Care

[ Thu, Jan 26th 2012 ] - Market Wire

NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign

[ Thu, Jan 26th 2012 ] - Market Wire

Celgene to Acquire Avila Therapeutics

[ Thu, Jan 26th 2012 ] - Market Wire

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX Phase Ib Cellulite Study

[ Thu, Jan 26th 2012 ] - Market Wire

Nutraceutical Reports Fiscal 2012 Q1 Results

[ Thu, Jan 26th 2012 ] - Market Wire

Soligenix Receives $574,000 in Non-Dilutive Finan .. hnology Business Tax Certificate Transfer Program

[ Thu, Jan 26th 2012 ] - Market Wire

Initial Clinical Data Reveal Potential of Tasimel .. the Body Clock in Non-24-Hour Sleep-Wake Disorder

[ Thu, Jan 26th 2012 ] - Market Wire

Illumina Adopts Stockholder Rights Agreement

Wed, January 25, 2012

[ Wed, Jan 25th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of TranS1 Inc.

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead start een Fase 2 klinisch onderzoek voor d .. n lage-dosis nieuwe prodrug van Tenofovir voor de

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead avvia una sperimentazione clinica di Fase .. 340, un nuovo profarmaco di tenofovir a basso dos

[ Wed, Jan 25th 2012 ] - Market Wire

Law Firm Brower Piven Announces Investigation in .. e Possible Acquisition of Illumina, Inc. by Roche

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead inicia ensayo clnico de Fase 2 que evala G .. e baja dosis de tenofovir para el tratamiento del

[ Wed, Jan 25th 2012 ] - Market Wire

Harwood Feffer LLP Announces Investigation of Illumina Inc.

[ Wed, Jan 25th 2012 ] - Market Wire

Thoratec Schedules Fourth Quarter Conference Call, Webcast

[ Wed, Jan 25th 2012 ] - Market Wire

Investigation of Chemed Corporation Shareholder Claims by Goldfarb Branham Law Firm LLP

[ Wed, Jan 25th 2012 ] - Market Wire

ZELTIQ spant rechtszaak aan tegen Clinipro wegens patentinbreuk

[ Wed, Jan 25th 2012 ] - Market Wire

Neurocrine Biosciences Announces The FDA Has Gran .. t Track Designation For VMAT2 Inhibitor NBI-98854

[ Wed, Jan 25th 2012 ] - Market Wire

Medtronic and Guided Therapeutics Poised for Growth

[ Wed, Jan 25th 2012 ] - Market Wire

Antares Pharma and Boston Scientific Benefit From Renewed Industry Optimism

[ Wed, Jan 25th 2012 ] - Market Wire

Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System

[ Wed, Jan 25th 2012 ] - Market Wire

ZELTIQ Initiates Patent Infringement Lawsuit Against Clinipro

[ Wed, Jan 25th 2012 ] - Market Wire

Dados Clnicos para o Estudo da DURABILIDADE II Apresentado na ISET 2012

[ Wed, Jan 25th 2012 ] - Market Wire

Donnes cliniques pour l'tude DURABILITY II prsente lors de l'ISET 2012

[ Wed, Jan 25th 2012 ] - Market Wire

FDA actualiseert TYSABRI (natalizumab) label en v .. s antilichaam status toe als een PML risicofactor

[ Wed, Jan 25th 2012 ] - Market Wire

Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508

[ Wed, Jan 25th 2012 ] - Market Wire

DaVita Acquires Majority Stake in NephroLife India

[ Wed, Jan 25th 2012 ] - Market Wire

Cord Blood America Reports that Umbilical Cord Bl .. Used in Experimental Effort to Treat Type 1 Diabe

Tue, January 24, 2012

[ Tue, Jan 24th 2012 ] - Market Wire

Quarterly Report I 11/12

[ Tue, Jan 24th 2012 ] - Market Wire

Codexis Announces CFO Departure

[ Tue, Jan 24th 2012 ] - Market Wire

Mylan to Host Investor Day on Feb. 21, 2012, in New York City

[ Tue, Jan 24th 2012 ] - Market Wire

Oramed Pharmaceuticals Granted Australian Patent .. pany's Core Technology in Oral Delivery of Protei

[ Tue, Jan 24th 2012 ] - Market Wire

Cleveland BioLabs Announces Management Reorganization

[ Tue, Jan 24th 2012 ] - Market Wire

Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates

[ Tue, Jan 24th 2012 ] - Market Wire

Psychemedics Awarded Patent Fundamental To Hair Analysis Drug Testing

[ Tue, Jan 24th 2012 ] - Market Wire

Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors

[ Tue, Jan 24th 2012 ] - Market Wire

Booming Stem Cell Market Benefits Advanced Cell Technology and Neostem

[ Tue, Jan 24th 2012 ] - Market Wire

Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry

[ Tue, Jan 24th 2012 ] - Market Wire

Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients

[ Tue, Jan 24th 2012 ] - Market Wire

Adipose Stem Cell Heart Attack Trial Data Publish .. College of Cardiology;; Cytori's APOLLO T

[ Tue, Jan 24th 2012 ] - Market Wire

Spectranetics Strengthens Peripheral Vascular Por .. a Partnership to Distribute the TAPASa" Catheter

[ Tue, Jan 24th 2012 ] - Market Wire

BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C

[ Tue, Jan 24th 2012 ] - Market Wire

PDL BioPharma Announces 2012 Regular Quarterly Dividends

[ Tue, Jan 24th 2012 ] - Market Wire

Quest Diagnostics Increases Share Repurchase Authority by $1 Billion

[ Tue, Jan 24th 2012 ] - Market Wire

Covidien verffentlicht klinische Daten ber Plaque-Exzision zur Behandlung kalzifizierter Lsionen

[ Tue, Jan 24th 2012 ] - Market Wire

TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City

[ Tue, Jan 24th 2012 ] - Market Wire

OncoSec to Present at World Cancer Immunotherapy Conference

[ Tue, Jan 24th 2012 ] - Market Wire

Dhr. Richard W. Barker wordt lid Raad van Bestuur van Celgene Corporation

Mon, January 23, 2012

[ Mon, Jan 23rd 2012 ] - Market Wire

VELscope Vx(R) System Approved for Use by Heartland Dental Care

[ Mon, Jan 23rd 2012 ] - Market Wire

Celgene Corporation incorpora a su Consejo de Administracin al Dr. Richard W. Barker

[ Mon, Jan 23rd 2012 ] - Market Wire

Medicure Provides Update on TEND-TD Phase II Clinical Trial

[ Mon, Jan 23rd 2012 ] - Market Wire

Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc.

[ Mon, Jan 23rd 2012 ] - Market Wire

Fresh Start Private Renews Advertising Agreement With Clear Channel Los Angeles Until 2013

[ Mon, Jan 23rd 2012 ] - Market Wire

UnitedHealth Group, The Goldman Sachs, Tiffany & Company, News Corporation and School Specialty

[ Mon, Jan 23rd 2012 ] - Market Wire

Verisante Aura Clinical Study Data Analysis Presented at SPIE

[ Mon, Jan 23rd 2012 ] - Market Wire

OPKO Health Acquires Next Generation Prostate Cancer Tests

[ Mon, Jan 23rd 2012 ] - Market Wire

Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board

[ Mon, Jan 23rd 2012 ] - Market Wire

Medtronic Announces 510(k) Clearance for the Aqua .. SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery

[ Mon, Jan 23rd 2012 ] - Market Wire

Alerea" Rapid Flu Test Receives CLIA Waiver from FDA

[ Mon, Jan 23rd 2012 ] - Market Wire

Canada's First National Public Cord Blood Bank Ad .. ThermoGenesis BioArchive Cryopreservation System

[ Mon, Jan 23rd 2012 ] - Market Wire

MyMedicalRecords to Introduce Mobile Phone and Tablet App at HIMSS

[ Mon, Jan 23rd 2012 ] - Market Wire

Boston Scientific Announces Favorable Ruling in Patent Infringement Case

[ Mon, Jan 23rd 2012 ] - Market Wire

Amarantus BioSciences Licenses Parkinsonas Diseas .. ostic Biomarker Test from Power3 Medical Products

[ Mon, Jan 23rd 2012 ] - Market Wire

The Medicines Company Settles Angiomax(R) (Bivali .. udin) Patent Litigations With App Pharmaceuticals

[ Mon, Jan 23rd 2012 ] - Market Wire

EntreMed Secures $10 Million Strategic Financing

[ Mon, Jan 23rd 2012 ] - Market Wire

Marina Biotech Receives Notice of Acceptance for .. g Its Unlocked Nucleobase Analog (UNA) Technology

[ Mon, Jan 23rd 2012 ] - Market Wire

BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board

[ Mon, Jan 23rd 2012 ] - Market Wire

PAREXEL Expands Alliance Network to Support Early .. lishes Collaboration With University Hospitals Br

Sun, January 22, 2012

[ Sun, Jan 22nd 2012 ] - Market Wire

Helix BioPharma Corp. Responds to Dissident Proxy .. ion With the January 30, 2012 Shareholder Meeting

Sat, January 21, 2012

[ Sat, Jan 21st 2012 ] - Market Wire

L'FDA aggiorna l'etichetta del TYSABRI (natalizum .. egli anticorpi anti-JCV come fattore di rischio d

[ Sat, Jan 21st 2012 ] - Market Wire

FDA aktualisiert Produktinformationen fr TYSABRI .. des JC-Virus-Antikrperstatus als Risikofaktor fr

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l' .. zumab) pour y inclure le statut daanticorps anti-

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. de TYSABRI (natalizumab) pour y inclure le statut

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;tiquetage de TYSABRI (natalizumab) p

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;tiquetage de TYSABRI (na

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;tiquetage de TYS

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;tiquetage de

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;tiquetag

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;tiqu

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012

_{//health-fitness.news-articles.net/content/2012/ .. nancial-results-on-thursday-february-2-2012.html}
^{Published in Health and Fitness on Thursday, January 26th 2012 at 13:41 GMT by Market Wire}

FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its fourth quarter and year end 2011 financial results will be released on Thursday, February 2, at 4:05 p.m. Eastern Time. At 5:00 p.m. Eastern Time, Gileadas management will host a conference call to discuss the companyas financial results for the fourth quarter and full year 2011 and provide a general business update and financial guidance for 2012. The conference call will be accessible via the internet from the companyas website.

To access the webcast link, log on to [ www.gilead.com ]. Please connect to the companyas website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 1-800-260-8140 (U.S.) or 1-617-614-3672 (international) and dial the participant passcode 15171649 to access the call. Telephone replay will be available approximately two hours after the call through 11:59 p.m. Eastern Time, February 6, 2012. To access the replay, please call 1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the participant passcode 32699245. The webcast will be archived on [ www.gilead.com ] for one year.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The companyas mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit [ www.gilead.com ] or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire